{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:27:08Z","timestamp":1792790828540,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1038\/s41591-020-0867-7","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T12:06:36Z","timestamp":1589803596000},"page":"892-899","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":282,"title":["Predicting conversion to wet age-related macular degeneration using deep learning"],"prefix":"10.1038","volume":"26","author":[{"given":"Jason","family":"Yim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4264-8329","authenticated-orcid":false,"given":"Reena","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9791-3767","authenticated-orcid":false,"given":"Terry","family":"Spitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Winkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Obika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1246-844X","authenticated-orcid":false,"given":"Christopher","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Askham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7636-8368","authenticated-orcid":false,"given":"Marko","family":"Lukic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Huemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Fasler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6901-0985","authenticated-orcid":false,"given":"Cian","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9623-7007","authenticated-orcid":false,"given":"Geraint","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8087-2268","authenticated-orcid":false,"given":"Peng T.","family":"Khaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Karthikesalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demis","family":"Hassabis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Suleyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Back","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9917-7196","authenticated-orcid":false,"given":"Joseph R.","family":"Ledsam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9239-745X","authenticated-orcid":false,"given":"Pearse A.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6971-5678","authenticated-orcid":false,"given":"Jeffrey","family":"De Fauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,18]]},"reference":[{"key":"867_CR1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature21056","volume":"542","author":"A Esteva","year":"2017","unstructured":"Esteva, A. et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature 542, 115\u2013118 (2017).","journal-title":"Nature"},{"key":"867_CR2","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/s41591-018-0107-6","volume":"24","author":"J De Fauw","year":"2018","unstructured":"De Fauw, J. et al. Clinically applicable deep learning for diagnosis and referral in retinal disease. Nat. Med. 24, 1342\u20131350 (2018).","journal-title":"Nat. Med."},{"key":"867_CR3","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-019-0447-x","volume":"25","author":"D Ardila","year":"2019","unstructured":"Ardila, D. et al. End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nat. Med. 25, 954\u2013961 (2019).","journal-title":"Nat. Med."},{"key":"867_CR4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41551-018-0195-0","volume":"2","author":"R Poplin","year":"2018","unstructured":"Poplin, R. et al. Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning. Nat. Biomed. Eng. 2, 158\u2013164 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"867_CR5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41586-019-1390-1","volume":"572","author":"N Toma\u0161ev","year":"2019","unstructured":"Toma\u0161ev, N. et al. A clinically applicable approach to continuous prediction of future acute kidney injury. Nature 572, 116\u2013119 (2019).","journal-title":"Nature"},{"key":"867_CR6","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong, W. L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob. Health 2, e106\u2013e116 (2014).","journal-title":"Lancet Glob. Health"},{"key":"867_CR7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/bjophthalmol-2011-301109","volume":"96","author":"CG Owen","year":"2012","unstructured":"Owen, C. G. et al. The estimated prevalence and incidence of late stage age related macular degeneration in the UK. Br. J. Ophthalmol. 96, 752\u2013756 (2012).","journal-title":"Br. J. Ophthalmol."},{"key":"867_CR8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/archophthalmol.2009.58","volume":"127","author":"DB Rein","year":"2009","unstructured":"Rein, D. B. et al. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Arch. Ophthalmol. 127, 533\u2013540 (2009).","journal-title":"Arch. Ophthalmol."},{"key":"867_CR9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ajo.2015.04.003","volume":"160","author":"AR Rudnicka","year":"2015","unstructured":"Rudnicka, A. R. et al. Incidence of late-stage age-related macular degeneration in American whites: systematic review and meta-analysis. Am. J. Ophthalmol. 160, 85\u201393 (2015).","journal-title":"Am. J. Ophthalmol."},{"key":"867_CR10","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ajo.2011.09.013","volume":"153","author":"JH Lim","year":"2012","unstructured":"Lim, J. H. et al. Delay to treatment and visual outcomes in patients treated with anti-vascular endothelial growth factor for age-related macular degeneration. Am. J. Ophthalmol. 153, 678\u2013686 (2012).","journal-title":"Am. J. Ophthalmol."},{"key":"867_CR11","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1007\/s00417-018-4100-z","volume":"256","author":"T Bek","year":"2018","unstructured":"Bek, T. & Klug, S. E. Incidence and risk factors for neovascular age-related macular degeneration in the fellow eye. Graefes Arch. Clin. Exp. Ophthalmol. 256, 2061\u20132068 (2018).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"867_CR12","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.ophtha.2014.04.026","volume":"121","author":"J Zarranz-Ventura","year":"2014","unstructured":"Zarranz-Ventura, J. et al. The neovascular age-related macular degeneration database: report 2: incidence, management, and visual outcomes of second treated eyes. Ophthalmology 121, 1966\u20131975 (2014).","journal-title":"Ophthalmology"},{"key":"867_CR13","doi-asserted-by":"publisher","unstructured":"Fasler, K. et al. The Moorfields AMD Database Report 2 \u2013 Fellow Eye Involvement with Neovascular Age-related Macular Degeneration. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/615252 (2019).","DOI":"10.1101\/615252"},{"key":"867_CR14","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.ophtha.2013.03.017","volume":"120","author":"MG Maguire","year":"2013","unstructured":"Maguire, M. G. et al. Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials. Ophthalmology 120, 2035\u20132041 (2013).","journal-title":"Ophthalmology"},{"key":"867_CR15","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/eye.2011.343","volume":"26","author":"W Amoaku","year":"2012","unstructured":"Amoaku, W. et al. Action on AMD. Optimising patient management: act now to ensure current and continual delivery of best possible patient care. Eye 26, S2\u2013S21 (2012).","journal-title":"Eye"},{"key":"867_CR16","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1001\/archophthalmol.2009.312","volume":"127","author":"EY Chew","year":"2009","unstructured":"Chew, E. Y., Lindblad, A. S. & Clemons, T. Summary results and recommendations from the Age-Related Eye Disease Study. Arch. Ophthalmol. 127, 1678 (2009).","journal-title":"Arch. Ophthalmol."},{"key":"867_CR17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/bjo.2006.101022","volume":"91","author":"SY Cohen","year":"2007","unstructured":"Cohen, S. Y. et al. Prevalence of reticular pseudodrusen in age-related macular degeneration with newly diagnosed choroidal neovascularisation. Br. J. Ophthalmol. 91, 354\u2013359 (2007).","journal-title":"Br. J. Ophthalmol."},{"key":"867_CR18","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.ophtha.2010.01.027","volume":"117","author":"SA Zweifel","year":"2010","unstructured":"Zweifel, S. A., Imamura, Y., Spaide, T. C., Fujiwara, T. & Spaide, R. F. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology 117, 1775\u20131781 (2010).","journal-title":"Ophthalmology"},{"key":"867_CR19","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.ophtha.2016.02.043","volume":"123","author":"Q Zhou","year":"2016","unstructured":"Zhou, Q. et al. Pseudodrusen and Incidence of late age-related macular degeneration in fellow eyes in the comparison of age-related macular degeneration treatments trials. Ophthalmology 123, 1530\u20131540 (2016).","journal-title":"Ophthalmology"},{"key":"867_CR20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajo.2019.07.013","volume":"208","author":"J Lee","year":"2019","unstructured":"Lee, J. et al. Neovascularization in fellow eye of unilateral neovascular age-related macular degeneration according to different drusen types. Am. J. Ophthalmol. 208, 103\u2013110 (2019).","journal-title":"Am. J. Ophthalmol."},{"key":"867_CR21","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.ophtha.2016.08.047","volume":"123","author":"M Veerappan","year":"2016","unstructured":"Veerappan, M. et al. Optical coherence tomography reflective drusen substructures predict progression to geographic atrophy in age-related macular degeneration. Ophthalmology 123, 2554\u20132570 (2016).","journal-title":"Ophthalmology"},{"key":"867_CR22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajo.2011.02.004","volume":"152","author":"BL VanderBeek","year":"2011","unstructured":"VanderBeek, B. L. et al. Racial differences in age-related macular degeneration rates in the United States: a longitudinal analysis of a managed care network. Am. J. Ophthalmol. 152, 273\u2013282 (2011).","journal-title":"Am. J. Ophthalmol."},{"key":"867_CR23","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1001\/archopht.123.11.1570","volume":"123","author":"Age-Related Eye Disease Study Research Group.","year":"2005","unstructured":"Age-Related Eye Disease Study Research Group.A simplified severity scale for age-related macular degeneration. Arch. Ophthal. 123, 1570\u20131574 (2005).","journal-title":"Arch. Ophthal."},{"key":"867_CR24","first-page":"359","volume":"106","author":"S Tonekaboni","year":"2019","unstructured":"Tonekaboni, S., Joshi, S., McCradden, M. D. & Goldenberg, A. M. What clinicians want: contextualizing explainable machine learning for clinical end use. Proc. Mach. Learn. Res. 106, 359\u2013380 (2019).","journal-title":"Proc. Mach. Learn. Res."},{"key":"867_CR25","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0002-9394(01)01218-1","volume":"132","author":"Age-Related Eye Disease Study Research Group.","year":"2001","unstructured":"Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs. Am. J. Ophthalmol. 132, 668\u2013681 (2001).","journal-title":"Am. J. Ophthalmol."},{"key":"867_CR26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/IAE.0000000000001540","volume":"38","author":"S Fragiotta","year":"2018","unstructured":"Fragiotta, S., Rossi, T., Cutini, A., Grenga, P. L. & Vingolo, E. M. Predictive factors for development of neovascular age-related macular degeneration: a spectral-domain optical coherence tomography study. Retina 38, 245\u2013252 (2018).","journal-title":"Retina"},{"key":"867_CR27","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1167\/iovs.18-24106","volume":"59","author":"U Schmidt-Erfurth","year":"2018","unstructured":"Schmidt-Erfurth, U. et al. Prediction of individual disease conversion in early AMD using artificial intelligence. Invest. Ophthalmol. Vis. Sci. 59, 3199\u20133208 (2018).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"867_CR28","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1167\/iovs.15-18572","volume":"57","author":"NS Abdelfattah","year":"2016","unstructured":"Abdelfattah, N. S. et al. Drusen volume as a predictor of disease progression in patients with late age-related macular degeneration in the fellow eye. Invest. Ophthalmol. Vis. Sci. 57, 1839\u20131846 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"867_CR29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ophtha.2015.09.016","volume":"123","author":"FA Folgar","year":"2016","unstructured":"Folgar, F. A. et al. Drusen volume and retinal pigment epithelium abnormal thinning volume predict 2-year progression of age-related macular degeneration. Ophthalmology 123, 39\u201350 (2016).","journal-title":"Ophthalmology"},{"key":"867_CR30","unstructured":"NIHR Oxford Biomedical Research Centre. World\u2019s First Gene Therapy Operation for Common Cause of Sight Loss Carried Out https:\/\/oxfordbrc.nihr.ac.uk\/worlds-first-gene-therapy-operation-for-common-cause-of-sight-loss-carried-out\/ (2019)."},{"key":"867_CR31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ophtha.2019.04.017","volume":"127","author":"PU Dugel","year":"2020","unstructured":"Dugel, P. U. et al. HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration. Ophthalmology 127, 72\u201384 (2020).","journal-title":"Ophthalmology"},{"key":"867_CR32","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ophtha.2019.03.023","volume":"126","author":"J Sahni","year":"2019","unstructured":"Sahni, J. et al. Simultaneous Inhibition of angiopoietin-2 and vascular endothelial growth factor-a with faricimab in diabetic macular edema: BOULEVARD phase 2 randomized trial. Ophthalmology 126, 1155\u20131170 (2019).","journal-title":"Ophthalmology"},{"key":"867_CR33","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.ophtha.2019.03.036","volume":"126","author":"PA Campochiaro","year":"2019","unstructured":"Campochiaro, P. A. et al. The port delivery system with ranibizumab for neovascular age-related macular degeneration: results from the randomized phase 2 ladder clinical trial. Ophthalmology 126, 1141\u20131154 (2019).","journal-title":"Ophthalmology"},{"key":"867_CR34","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00417-010-1520-9","volume":"249","author":"PS Muether","year":"2011","unstructured":"Muether, P. S., Hermann, M. M., Koch, K. & Fauser, S. Delay between medical indication to anti-VEGF treatment in age-related macular degeneration can result in a loss of visual acuity. Graefes Arch. Clin. Exp. Ophthalmol. 249, 633\u2013637 (2011).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"867_CR35","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.ophtha.2016.01.044","volume":"123","author":"L Roisman","year":"2016","unstructured":"Roisman, L. et al. Optical coherence tomography angiography of asymptomatic neovascularization in intermediate age-related macular degeneration. Ophthalmology 123, 1309\u20131319 (2016).","journal-title":"Ophthalmology"},{"key":"867_CR36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ophtha.2017.08.030","volume":"125","author":"JR de Oliveira Dias","year":"2018","unstructured":"de Oliveira Dias, J. R. et al. Natural history of subclinical neovascularization in nonexudative age-related macular degeneration using swept-source oct angiography. Ophthalmology 125, 255\u2013266 (2018).","journal-title":"Ophthalmology"},{"key":"867_CR37","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.oret.2018.02.002","volume":"2","author":"A Carnevali","year":"2018","unstructured":"Carnevali, A. et al. Natural history of treatment-na\u00efve quiescent choroidal neovascularization in age-related macular degeneration using OCT angiography. Ophthalmol. Retina 2, 922\u2013930 (2018).","journal-title":"Ophthalmol. Retina"},{"key":"867_CR38","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1056\/NEJMra0801537","volume":"358","author":"RD Jager","year":"2008","unstructured":"Jager, R. D., Mieler, W. F. & Miller, J. W. Age-related macular degeneration. N. Engl. J. Med. 358, 2606\u20132617 (2008).","journal-title":"N. Engl. J. Med."},{"key":"867_CR39","unstructured":"Babenko, B. et al. Predicting progression of age-related macular degeneration from fundus images using deep learning. Preprint at https:\/\/arxiv.org\/abs\/1904.05478 (2019)."},{"key":"867_CR40","doi-asserted-by":"crossref","first-page":"BIO141","DOI":"10.1167\/iovs.17-21789","volume":"58","author":"H Bogunovic","year":"2017","unstructured":"Bogunovic, H. et al. Machine learning of the progression of intermediate age-related macular degeneration based on OCT Imaging. Invest. Ophthalmol. Vis. Sci. 58, BIO141\u2013BIO150 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"867_CR41","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1167\/iovs.18-25325","volume":"60","author":"DB Russakoff","year":"2019","unstructured":"Russakoff, D. B., Lamin, A., Oakley, J. D., Dubis, A. M. & Sivaprasad, S. Deep learning for prediction of AMD progression: a pilot study. Invest. Ophthalmol. Vis. Sci. 60, 712\u2013722 (2019).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"867_CR42","unstructured":"Banerjee, I. et al. A deep-learning approach for prognosis of age-related macular degeneration disease using SD-OCT imaging biomarkers. Preprint at https:\/\/arxiv.org\/abs\/1902.10700 (2019)."},{"key":"867_CR43","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.ophtha.2018.01.034","volume":"125","author":"J Krause","year":"2018","unstructured":"Krause, J. et al. Grader variability and the importance of reference standards for evaluating machine learning models for diabetic retinopathy. Ophthalmology 125, 1264\u20131272 (2018).","journal-title":"Ophthalmology"},{"key":"867_CR44","first-page":"119","volume":"2006","author":"JF Vander","year":"2006","unstructured":"Vander, J. F. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS). Yearb. Ophthalmol. 2006, 119\u2013121 (2006).","journal-title":"Yearb. Ophthalmol."},{"key":"867_CR45","unstructured":"UK Information Commissioner\u2019s Office. Anonymisation: Managing Data Protection Risk Code of Practice (2015)."},{"key":"867_CR46","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.12688\/f1000research.8996.1","volume":"5","author":"J De Fauw","year":"2016","unstructured":"De Fauw, J. et al. Automated analysis of retinal imaging using machine learning techniques for computer vision. F1000Res. 5, 1573 (2016).","journal-title":"F1000Res."},{"key":"867_CR47","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1167\/iovs.16-19816","volume":"57","author":"C Balaratnasingam","year":"2016","unstructured":"Balaratnasingam, C. et al. Associations between retinal pigment epithelium and drusen volume changes during the lifecycle of large drusenoid pigment epithelial detachments. Invest. Ophthalmol. Vis. Sci. 57, 5479\u20135489 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"867_CR48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ajo.2016.09.008","volume":"172","author":"C Balaratnasingam","year":"2016","unstructured":"Balaratnasingam, C. et al. Clinical characteristics, choroidal neovascularization, and predictors of visual outcomes in acquired vitelliform lesions. Am. J. Ophthalmol. 172, 28\u201338 (2016).","journal-title":"Am. J. Ophthalmol."},{"key":"867_CR49","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.oret.2018.01.005","volume":"2","author":"JJ Lek","year":"2018","unstructured":"Lek, J. J. et al. Interpretation of subretinal fluid using OCT in intermediate age-related macular degeneration. Ophthalmol. Retina 2, 792\u2013802 (2018).","journal-title":"Ophthalmol. Retina"},{"key":"867_CR50","doi-asserted-by":"crossref","unstructured":"\u00c7i\u00e7ek, \u00d6., Abdulkadir, A., Lienkamp, S. S., Brox, T. & Ronneberger, O. 3D U-Net: learning dense volumetric segmentation from sparse annotation. In Medical Image Computing and Computer-Assisted Intervention \u2013 MICCAI 2016 Vol. 9901, 424\u2013432 (Springer, 2016).","DOI":"10.1007\/978-3-319-46723-8_49"},{"key":"867_CR51","unstructured":"Abadi, M. et al. TensorFlow: large-scale machine learning on heterogeneous distributed systems. Preprint at https:\/\/arxiv.org\/abs\/1603.04467 (2016)."},{"key":"867_CR52","unstructured":"Reynolds, M. et al. Open Sourcing Sonnet \u2013 A New Library for Constructing Neural Networks (DeepMind, accessed 26 July 2019); https:\/\/deepmind.com\/blog\/open-sourcing-sonnet\/"},{"key":"867_CR53","unstructured":"Buchlovsky, P. et al. TF-Replicator: distributed machine learning for researchers. Preprint at https:\/\/arxiv.org\/abs\/1902.00465 (2019)."},{"key":"867_CR54","doi-asserted-by":"crossref","first-page":"BIO211","DOI":"10.1167\/iovs.16-19778","volume":"58","author":"CA Curcio","year":"2017","unstructured":"Curcio, C. A., Zanzottera, E. C., Ach, T., Balaratnasingam, C. & Freund, K. B. Activated retinal pigment epithelium, an optical coherence tomography biomarker for progression in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 58, BIO211\u2013BIO226 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"867_CR55","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.ophtha.2012.10.018","volume":"120","author":"JG Christenbury","year":"2013","unstructured":"Christenbury, J. G. et al. and Age-Related Eye Disease Study 2 Ancillary Spectral Domain Optical Coherence Tomography Study Group. Progression of intermediate age-related macular degeneration with proliferation and inner retinal migration of hyperreflective foci. Ophthalmology 120, 1038\u20131045 (2013).","journal-title":"Ophthalmology"},{"key":"867_CR56","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1167\/iovs.12-9813","volume":"53","author":"FA Folgar","year":"2012","unstructured":"Folgar, F. A. et al. Spatial correlation between hyperpigmentary changes on color fundus photography and hyperreflective foci on SDOCT in intermediate AMD. Invest. Ophthalmol. Vis. Sci. 53, 4626\u20134633 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"867_CR57","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0161-6420(00)00409-7","volume":"107","author":"Age-Related Eye Disease Study Research Group.","year":"2000","unstructured":"Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: age-related eye disease study report number 3. Ophthalmology 107, 2224\u20132232 (2000).","journal-title":"Ophthalmology"},{"key":"867_CR58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0161-6420(97)30368-6","volume":"104","author":"R Klein","year":"1997","unstructured":"Klein, R., Klein, B. E., Jensen, S. C. & Meuer, S. M. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104, 7\u201321 (1997).","journal-title":"Ophthalmology"},{"key":"867_CR59","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1001\/archopht.1990.01070120090035","volume":"108","author":"SB Bressler","year":"1990","unstructured":"Bressler, S. B., Maguire, M. G., Bressler, N. M. & Fine, S. L. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group. Arch. Ophthalmol. 108, 1442\u20131447 (1990).","journal-title":"Arch. Ophthalmol."},{"key":"867_CR60","unstructured":"Hinton, G., Vinyals, O. & Dean, J. Distilling the knowledge in a neural network. Preprint at https:\/\/arxiv.org\/abs\/1503.02531 (2015)."},{"key":"867_CR61","unstructured":"Huang, G., Liu, Z., Van Der Maaten, L. & Weinberger, K. Q. In Proc. IEEE Conference on Computer Vision and Pattern Recognition 4700\u20134708 (CVPR, 2017)."},{"key":"867_CR62","unstructured":"Xie, S., Sun, C., Huang, J., Tu, Z. & Murphy, K. In Proc. European Conference on Computer Vision 305\u2013321 (Springer, 2018)."},{"key":"867_CR63","unstructured":"Kingma, D .P. & Ba, J. Adam: a method for stochastic optimization. Preprint at https:\/\/arxiv.org\/abs\/1412.6980 (2014)."},{"key":"867_CR64","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","volume":"125","author":"SR Sadda","year":"2018","unstructured":"Sadda, S. R. et al. Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3. Ophthalmology 125, 537\u2013548 (2018).","journal-title":"Ophthalmology"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41591-020-0867-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41591-020-0867-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41591-020-0867-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:02:52Z","timestamp":1684605772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-020-0867-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,18]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["867"],"URL":"https:\/\/doi.org\/10.1038\/s41591-020-0867-7","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,18]]},"assertion":[{"value":"23 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.A.K. and G.R. are paid contractors of DeepMind. P.A.K. has received speaker fees from Heidelberg Engineering, Topcon, Haag-Streit, Allergan, Novartis and Bayer. P.A.K. has served on advisory boards for Novartis and Bayer, and is an external consultant for DeepMind and Optos. M.L. received travel grants and a speaker fee from Bayer.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}